Education
About Us
Working with TipRanks
Follow Us
Isofol Medical AB (SE:ISOFOL)
:ISOFOL
ISOFOL Stock Chart & Stats
kr0.71
-kr0.10(-6.34%)
At close: 4:00 PM EST
kr0.71
-kr0.10(-6.34%)
Day’s Range― - ―
52-Week Rangekr0.66 - kr2.46
Previous CloseN/A
Volume134.77K
Average Volume (3M)501.89K
Market Cap
kr199.59M
Enterprise Valuekr70.24M
Total Cash (Recent Filing)kr138.79M
Total Debt (Recent Filing)kr0.00
Price to Earnings (P/E)―
Beta0.54
Next Earnings
Feb 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding281,107,240
10 Day Avg. Volume847,726
30 Day Avg. Volume501,890
Financial Highlights & Ratios
PEG Ratio-0.47
Price to Book (P/B)4.59
Price to Sales (P/S)0.00
P/FCF Ratio-8.52
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Isofol Medical AB News
ISOFOL FAQ
What was Isofol Medical AB’s price range in the past 12 months?
Isofol Medical AB lowest stock price was kr0.66 and its highest was kr2.46 in the past 12 months.
What is Isofol Medical AB’s market cap?
Isofol Medical AB’s market cap is kr199.59M.
When is Isofol Medical AB’s upcoming earnings report date?
Isofol Medical AB’s upcoming earnings report date is Feb 18, 2026 which is in 65 days.
How were Isofol Medical AB’s earnings last quarter?
Isofol Medical AB released its earnings results on Nov 12, 2025. The company reported -kr0.05 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.05.
Is Isofol Medical AB overvalued?
According to Wall Street analysts Isofol Medical AB’s price is currently Overvalued.
Does Isofol Medical AB pay dividends?
Isofol Medical AB does not currently pay dividends.
What is Isofol Medical AB’s EPS estimate?
Isofol Medical AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Isofol Medical AB have?
Isofol Medical AB has 281,107,240 shares outstanding.
What happened to Isofol Medical AB’s price movement after its last earnings report?
Isofol Medical AB reported an EPS of -kr0.05 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.146%.
Which hedge fund is a major shareholder of Isofol Medical AB?
Currently, no hedge funds are holding shares in SE:ISOFOL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Isofol Medical AB
Isofol Medical AB (ISOFOL) is a pharmaceutical company focused on developing oncology treatments. Headquartered in Sweden, the company is dedicated to improving the efficacy and safety of standard chemotherapy drugs. Its core product, arfolitixorin, is designed to enhance the effectiveness of folate-based cancer therapies, particularly in colorectal cancer. Isofol Medical aims to advance cancer care through innovative pharmaceutical solutions, addressing unmet medical needs in the oncology sector.
Technical Analysis
Xintela AB
―
IRLAB Therapeutics AB Class A
―
Modus Therapeutics Holding AB
―
Active Biotech AB
―
Bio-Works Technologies AB
―